ConductScience.org, home
DEFB4A: defensin beta 4A
API referenceFor AI assistants

Gene · 1673

NIH grants2,073

NIH grants whose papers are about the gene, through NIH's grant-paper links.

61 to 80 of 2,073

Download this page as JSON
GrantTitleDEFB4A papersNewest fiscal year
P30DK065988UNC Cystic Fibrosis Research and Translation Core Center22025
P30ES005022Rutgers Center for Environmental Exposure and Disease (CEED)22025
P30ES005605Environmental Health Sciences Research Center22025
P51OD011107California National Primate Research Center22025
R01AG017644English Longitudinal Study of Ageing - Renewal 202422025
R01AI137270Radical SAM-dependent methylation in antibiotic resistance22025
R01CA124633Pathogenesis and Treatment of NUT midline carcinoma22025
R01DK119359Biochemical mechanisms of beta cell protection through bromodomain inhibition22025
R01ES020382Air Pollution Effects on Transmission of Mycobacterium tuberculosis in Urban Slum Community in Uganda22025
R01GM127791Targeting ACOD1 to attenuate innate immune responses to lethal infections22025
R01NS116037Overcoming Resistance Mechanisms in Hedgehog and Myc-amplified Medulloblastoma22025
R35GM128840Discovering and Exploiting Selectivity within Tandem Bromodomains22025
R35GM142772Exploiting Water Network Perturbations in Protein Binding Sites22025
R37AI052453Cathelicidin in Skin Immunity22025
R37AI083139Role of Factor Acetylation in the Regulation of HIV Transcription22025
T32AI007163Training Program in Basic Immunology22025
T32CA009582Biochemical and Chemical Training for Cancer Research22025
T32DE014318Craniofacial Oral-biology Student Training in Academic Research (COSTAR)22025
T32EY007043Training Program in Vision Science22025
T32HG000045Institutional Training Grant in Genomic Science22025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Previous pageNext page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/1673/grants?page=4

API referenceFor AI assistants